Abstract
An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19’s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference138 articles.
1. Pseudoscience and Fraudulent Products for COVID-19 Management;Chavda;Environ. Sci. Pollut. Res. Int.,2022
2. Chavda, V.P., Feehan, J., and Apostolopoulos, V. (2021). A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals. Vaccines, 9.
3. COVID-19 and Vaccination: Myths vs Science;Chavda;Expert Rev. Vaccines,2022
4. Emerging Concepts and Technologies in Vaccine Development;Brisse;Front. Immunol.,2020
5. Darunavir Ethanolate: Repurposing an Anti-HIV Drug in COVID-19 Treatment;Chavda;Eur. J. Med. Chem. Rep.,2021
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献